UK Medical Digital Imaging System Market Report 2023 to 2030

UK Medical Digital Imaging System Market Analysis

$ 3999

The UK Medical Digital Imaging System Market was valued at $793 Mn in 2023 and is predicted to grow at a CAGR of 6.2% from 2023 to 2030, to $1208.22 Mn by 2030. The key drivers of this industry include increasing chronic conditions, government support, and the aging population. The industry is primarily dominated by players such as Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems among others.

ID: IN10GBDH156 CATEGORY: Digital Health GEOGRAPHY: UK AUTHOR: Aashwi Mehta

Buy Now

UK Medical Digital Imaging System Market Executive Summary

The UK Medical Digital Imaging System Market was valued at $793 Mn in 2023 and is predicted to grow at a CAGR of 6.2% from 2023 to 2030, to $1208.22 Mn by 2030.

Medical digital imaging systems comprise various technologies employed in healthcare to create visual representations of the body's internal structures for clinical analysis and medical interventions. These systems have evolved considerably and are crucial in contemporary medicine, assisting in the diagnosis and treatment of diseases. Medical imaging encompasses ultrasound, x-rays, computed tomography (CT scans), Magnetic Resonance Imaging (MRI), and nuclear medicine technologies.

There were 45.3 Mn imaging tests reported in England during the year from September 2022 to August 2023. The market is driven by significant factors like increasing chronic conditions, government support, and the aging population. However, cost constraints, workforce shortage, and integration challenges restrict the growth and potential of the market.

Prominent players in this field include Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems among others.

UK Medical Digital Imaging System Market Report 2023 to 2030

Market Dynamics

Market Growth Drivers

Increasing Chronic Conditions: The projected increase to 9.1 Mn people living with major illnesses in England by 2040, up by 2.5 Mn from 2019, drives demand for medical digital imaging systems in the UK. These systems are crucial for diagnosing and monitoring conditions, supporting earlier detection and informed treatment decisions as healthcare needs grow.

Supportive Government Support: The Medical Research Council's investment in imaging research, funding centers, and networks across the UK, drives innovation and technological advancement in medical digital imaging systems. This support enhances diagnostic capabilities, fosters research collaboration, and positions the UK as a leader in medical imaging, thereby stimulating market growth.

Aging Population: The significant aging population in the UK, with over 11 Mn people aged 65 and projected to rise to 13 Mn in a decade (22% of the population), drives demand for medical digital imaging systems. These systems are crucial for diagnosing and monitoring age-related health conditions, supporting effective healthcare interventions as the elderly population increases.

Market Restraints

Cost Constraints: Medical imaging systems can be highly costly, especially the more advanced ones with the newest features. For hospitals and clinics with limited resources, this high cost can be a significant obstacle, making it challenging to replace, update, or purchase these systems. Thus, the financial strain brought on by these expenses limits the market's expansion for medical device imaging systems in the UK.

Workforce Shortage: The shortage of clinical radiologists in England, currently at 31% and projected to rise to 41% in five years, directly impedes the market for medical digital imaging systems in the UK by increasing patient waiting times for timely diagnoses.

Integration Challenges: The complexity of integrating with existing healthcare IT infrastructure and electronic health records (EHR) systems poses a key market restraint for the medical digital imaging system sector in the UK, leading to delays and higher costs.

Regulatory Landscape and Reimbursement Scenario

The UK government's Medical and Healthcare Products Regulatory Agency (MHRA) is in charge of regulating pharmaceuticals and medical devices. The MHRA is in charge of overseeing the regulation of pharmaceuticals, as well as the equipment and devices used in healthcare and conducting investigations into adverse events. In the UK, reimbursement for diagnostic tests is primarily handled through the National Health Service (NHS). It reimburses healthcare providers for the diagnostic imaging services they deliver, not for the imaging equipment used.

Competitive Landscape

Key Players

Here are some of the major key players in the UK Medical Digital Imaging System Market:

Siemens Healthineers
GE Healthcare
Philips Healthcare
Canon Medical Systems
Hitachi Medical
Fujifilm
Shimadzu
Konica Minolta
Hologic
Esaote

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

UK Medical Digital Imaging System Market Segmentation

By Type

X-Ray
MRI
CT scan
Ultrasound
Others

By Technology

2D Imaging System
3D/4D Imaging System

By Application

Orthopedics
Oncology
Cardiology
Neurology
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.